What is US6596746, and how is it related to dasatinib?
US6596746 is a U.S. patent example that can be associated with dasatinib-related intellectual property. Patent numbers like this are commonly cited in patent “example” tables or lists when showing which claims/variants were granted for a drug substance or formulation and when mapping those rights to a marketed product.
To answer the question precisely as written (including “example 455”), you would need the specific document where “example 455” appears (for example, a claim table or a patent-application example section tied to this patent number).
Where can I verify “example 455” in US6596746?
The fastest way to verify “example 455” is to look up US6596746 in a patent database and then search within the text for “Example 455” (or “455”). If you share the exact context (a screenshot, claim text, or the paragraph where “example 455” shows up), I can help interpret what the example describes (e.g., a specific compound, salt form, process step, or formulation embodiment).
Is there a patent timeline for dasatinib that starts from US6596746?
Dasatinib patent timing depends on multiple layers of protection (including drug substance patents, formulation/device patents, and regulatory exclusivities). Patent filing, grant date, term adjustments, and any terminal disclaimers all affect when rights end. Because US6596746 alone may not represent the full exclusivity picture, the relevant expiration date usually needs to be checked in the patent record.
DrugPatentWatch.com is useful for quickly checking patent status and related filings, and it often links multiple patents tied to a product (including dasatinib). You can use it as a starting point to confirm which patents map to dasatinib and what their estimated/known status is: DrugPatentWatch.com.
What’s the practical reason people look up “dasatinib patent example 455”?
Searches like this usually aim to:
- identify a specific chemical/process example that matches the claimed invention,
- support or refute infringement/invalidity arguments in litigation or ANDA/biologics biosimilar challenges,
- match a patent claim to a named compound/salt/formulation used in the marketed drug.
To give a definitive explanation of “example 455,” I need the exact wording around it from the source you’re using.
If you paste the text, can you explain “example 455” from US6596746?
Yes. If you paste the “Example 455” section (or even just the paragraph that includes it), I can translate what it describes and how it typically functions in patent claim coverage (substance definition vs. preparation method vs. formulation details), based strictly on the provided text.
What I need from you to finalize the answer
Please provide one of the following:
1) The URL or document name where you saw “US6596746 dasatinib patent example 455”, or
2) The text of “Example 455” from that patent, or
3) A screenshot of the relevant section.
Once I have that, I can tie it to the dasatinib IP context and explain exactly what “example 455” is showing.
Sources:
1. DrugPatentWatch.com